Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis.
Disclosure of diagnosis of multiple sclerosis in the workplace positively affects employment status and job tenure.
PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.
The treatment of neuromyelitis optica.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
Education protects against cognitive changes associated with multiple sclerosis.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
Reporting treatment outcomes in observational data: A fine balance.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
Improving Fatigue and Depression in Individuals With Multiple Sclerosis Using Telephone-Administered Physical Activity Counseling.
Proceedings of the 6th Dubrovnik International Conference on Multiple Sclerosis, 10-12 May 2012, Dubrovnik, Croatia.
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
Uhthoff phenomenon in osmotic demyelination syndrome.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Defective structural RNA processing in relapsing-remitting multiple sclerosis.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Pages
« first
‹ previous
…
527
528
529
530
531
532
533
534
535
…
next ›
last »